 




<DOCTITLE>Manufacturer of Controlled Substances; Notice of Registration</DOCTITLE>


By Notice dated May 3, 1994, and published in the 

Federal Register

 on May 10, 1994, (59 FR 24184), Roche Diagnostic Systems, Inc., 1080 U.S. Highway 202, Branchburg, New Jersey 08876,
made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed below:


<TABLE>



1Drug
1Schedule



Lysergic acid diethylamide (7315) 
I
Tetrahydrocannabinols (7370) 
I
Phencyclidine (7471) 
II
Methadone 
II

</TABLE>


No comments or objections have been received. Therefore, pursuant to Section 303 of the Comprehensive Drug Abuse
Prevention and Control Act of 1970 and Title 21, Code of Federal Regulations, Section 1301.54(e), the Deputy Assistant
Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration
as a bulk manufacturer of the basic classes of controlled substances listed above is granted.



Dated: July 20, 1994.


<SIGNER>
Gene R. Haislip,

</SIGNER>
<SIGNJOB>
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

</SIGNJOB>
<FRFILING>
[FR Doc. 9418343 Filed 72794; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 441009M
</BILLING>


